Eintrag weiter verarbeiten
Primary tumor sidedness associates with prognosis of patients with brain metastases of colorectal cancer.
Gespeichert in:
| Zeitschriftentitel: | Journal of Clinical Oncology |
|---|---|
| Personen und Körperschaften: | , , , , , , , , |
| In: | Journal of Clinical Oncology, 35, 2017, 15_suppl, S. 3562-3562 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
American Society of Clinical Oncology (ASCO)
|
| Schlagwörter: |
| author_facet |
Berghoff, Anna Sophie Ferreira, Pedro Plazer, Hanna Widhalm, Georg Birner, Peter Bartsch, Rupert Prager, Gerald W. Zielinski, Christoph Preusser, Matthias Berghoff, Anna Sophie Ferreira, Pedro Plazer, Hanna Widhalm, Georg Birner, Peter Bartsch, Rupert Prager, Gerald W. Zielinski, Christoph Preusser, Matthias |
|---|---|
| author |
Berghoff, Anna Sophie Ferreira, Pedro Plazer, Hanna Widhalm, Georg Birner, Peter Bartsch, Rupert Prager, Gerald W. Zielinski, Christoph Preusser, Matthias |
| spellingShingle |
Berghoff, Anna Sophie Ferreira, Pedro Plazer, Hanna Widhalm, Georg Birner, Peter Bartsch, Rupert Prager, Gerald W. Zielinski, Christoph Preusser, Matthias Journal of Clinical Oncology Primary tumor sidedness associates with prognosis of patients with brain metastases of colorectal cancer. Cancer Research Oncology |
| author_sort |
berghoff, anna sophie |
| spelling |
Berghoff, Anna Sophie Ferreira, Pedro Plazer, Hanna Widhalm, Georg Birner, Peter Bartsch, Rupert Prager, Gerald W. Zielinski, Christoph Preusser, Matthias 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2017.35.15_suppl.3562 <jats:p> 3562 </jats:p><jats:p> Background: Brian metastases (BM) are a rare but devastating complication of colorectal cancer. We aimed to analyse prognostic factors in patients suffering from colorectal cancer (CRC) BM. Methods: Patients with histological proven CRC and BM were identified from the brain metastasis database of the Comprehensive Cancer Center Vienna. Clinical characteristics including established prognostic factors were retrieved by chart review. Established clinical prognostic scores for BM patients including the graded prognostic assessment (GPA) and the GPA for gastrointestinal tumours (GI-GPA) were calculated based on clinical characteristics as previously published. Results: 215 (male: 125/215 (58.1%); female 90/215 (41.9%)) patients with CRC BM were available for this study. The following established clinical prognostic factors showed a significant association with median overall survival (OS) times from BM diagnosis: number of brain metastases (n = 1: 6 months; n = 2-3: 4 months; n > 3: 3 months; p = 0.001), age at BM diagnosis ( < 65 years: 6 months; > 65 years: 4 months; p = 0.047), extracranial disease (present: 4 months; absent: 8 months; p = 0.002) and Karfnofsky performance score (KPS < 70%: 3 months; KPS > 70%: 5 months; p = 0.002), graded prognostic assessment (GPA) class (class I: 15 months; class II: 13 months; class III: 4 months; class IV: 4 months) and the gastro-intestinal disease-specific GI-GPA (class I: 11 months; class II: 6 months; class III: 6 months; class IV: 3 months; p < 0.001). In addition, the location of the primary tumour in the left colon (n = 176 (81.9%); 5 months) was associated with significantly longer median overall survival times from diagnosis of BM than primary tumour location in the right colon (n = 39 (18.1%); 3 months; p = 0.010). Primary tumor sidedness (HR 0.577; 95% CI 0.397-0.841; p = 0.004) remained a strong prognostic factor at multivariate analysis independently of GI-GPA (HR 0.718; 95% CI 0.612-0.842). Conclusions: Primary tumor sidedness is an independent prognostic factor in patients with CRC BM and should be included in disease-specific prognostic scores. </jats:p> Primary tumor sidedness associates with prognosis of patients with brain metastases of colorectal cancer. Journal of Clinical Oncology |
| doi_str_mv |
10.1200/jco.2017.35.15_suppl.3562 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNy4zNS4xNV9zdXBwbC4zNTYy |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNy4zNS4xNV9zdXBwbC4zNTYy |
| institution |
DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 |
| imprint |
American Society of Clinical Oncology (ASCO), 2017 |
| imprint_str_mv |
American Society of Clinical Oncology (ASCO), 2017 |
| issn |
1527-7755 0732-183X |
| issn_str_mv |
1527-7755 0732-183X |
| language |
English |
| mega_collection |
American Society of Clinical Oncology (ASCO) (CrossRef) |
| match_str |
berghoff2017primarytumorsidednessassociateswithprognosisofpatientswithbrainmetastasesofcolorectalcancer |
| publishDateSort |
2017 |
| publisher |
American Society of Clinical Oncology (ASCO) |
| recordtype |
ai |
| record_format |
ai |
| series |
Journal of Clinical Oncology |
| source_id |
49 |
| title |
Primary tumor sidedness associates with prognosis of patients with brain metastases of colorectal cancer. |
| title_unstemmed |
Primary tumor sidedness associates with prognosis of patients with brain metastases of colorectal cancer. |
| title_full |
Primary tumor sidedness associates with prognosis of patients with brain metastases of colorectal cancer. |
| title_fullStr |
Primary tumor sidedness associates with prognosis of patients with brain metastases of colorectal cancer. |
| title_full_unstemmed |
Primary tumor sidedness associates with prognosis of patients with brain metastases of colorectal cancer. |
| title_short |
Primary tumor sidedness associates with prognosis of patients with brain metastases of colorectal cancer. |
| title_sort |
primary tumor sidedness associates with prognosis of patients with brain metastases of colorectal cancer. |
| topic |
Cancer Research Oncology |
| url |
http://dx.doi.org/10.1200/jco.2017.35.15_suppl.3562 |
| publishDate |
2017 |
| physical |
3562-3562 |
| description |
<jats:p> 3562 </jats:p><jats:p> Background: Brian metastases (BM) are a rare but devastating complication of colorectal cancer. We aimed to analyse prognostic factors in patients suffering from colorectal cancer (CRC) BM. Methods: Patients with histological proven CRC and BM were identified from the brain metastasis database of the Comprehensive Cancer Center Vienna. Clinical characteristics including established prognostic factors were retrieved by chart review. Established clinical prognostic scores for BM patients including the graded prognostic assessment (GPA) and the GPA for gastrointestinal tumours (GI-GPA) were calculated based on clinical characteristics as previously published. Results: 215 (male: 125/215 (58.1%); female 90/215 (41.9%)) patients with CRC BM were available for this study. The following established clinical prognostic factors showed a significant association with median overall survival (OS) times from BM diagnosis: number of brain metastases (n = 1: 6 months; n = 2-3: 4 months; n > 3: 3 months; p = 0.001), age at BM diagnosis ( < 65 years: 6 months; > 65 years: 4 months; p = 0.047), extracranial disease (present: 4 months; absent: 8 months; p = 0.002) and Karfnofsky performance score (KPS < 70%: 3 months; KPS > 70%: 5 months; p = 0.002), graded prognostic assessment (GPA) class (class I: 15 months; class II: 13 months; class III: 4 months; class IV: 4 months) and the gastro-intestinal disease-specific GI-GPA (class I: 11 months; class II: 6 months; class III: 6 months; class IV: 3 months; p < 0.001). In addition, the location of the primary tumour in the left colon (n = 176 (81.9%); 5 months) was associated with significantly longer median overall survival times from diagnosis of BM than primary tumour location in the right colon (n = 39 (18.1%); 3 months; p = 0.010). Primary tumor sidedness (HR 0.577; 95% CI 0.397-0.841; p = 0.004) remained a strong prognostic factor at multivariate analysis independently of GI-GPA (HR 0.718; 95% CI 0.612-0.842). Conclusions: Primary tumor sidedness is an independent prognostic factor in patients with CRC BM and should be included in disease-specific prognostic scores. </jats:p> |
| container_issue |
15_suppl |
| container_start_page |
3562 |
| container_title |
Journal of Clinical Oncology |
| container_volume |
35 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792324680794767378 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T11:53:32.444Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Primary+tumor+sidedness+associates+with+prognosis+of+patients+with+brain+metastases+of+colorectal+cancer.&rft.date=2017-05-20&genre=article&issn=1527-7755&volume=35&issue=15_suppl&spage=3562&epage=3562&pages=3562-3562&jtitle=Journal+of+Clinical+Oncology&atitle=Primary+tumor+sidedness+associates+with+prognosis+of+patients+with+brain+metastases+of+colorectal+cancer.&aulast=Preusser&aufirst=Matthias&rft_id=info%3Adoi%2F10.1200%2Fjco.2017.35.15_suppl.3562&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792324680794767378 |
| author | Berghoff, Anna Sophie, Ferreira, Pedro, Plazer, Hanna, Widhalm, Georg, Birner, Peter, Bartsch, Rupert, Prager, Gerald W., Zielinski, Christoph, Preusser, Matthias |
| author_facet | Berghoff, Anna Sophie, Ferreira, Pedro, Plazer, Hanna, Widhalm, Georg, Birner, Peter, Bartsch, Rupert, Prager, Gerald W., Zielinski, Christoph, Preusser, Matthias, Berghoff, Anna Sophie, Ferreira, Pedro, Plazer, Hanna, Widhalm, Georg, Birner, Peter, Bartsch, Rupert, Prager, Gerald W., Zielinski, Christoph, Preusser, Matthias |
| author_sort | berghoff, anna sophie |
| container_issue | 15_suppl |
| container_start_page | 3562 |
| container_title | Journal of Clinical Oncology |
| container_volume | 35 |
| description | <jats:p> 3562 </jats:p><jats:p> Background: Brian metastases (BM) are a rare but devastating complication of colorectal cancer. We aimed to analyse prognostic factors in patients suffering from colorectal cancer (CRC) BM. Methods: Patients with histological proven CRC and BM were identified from the brain metastasis database of the Comprehensive Cancer Center Vienna. Clinical characteristics including established prognostic factors were retrieved by chart review. Established clinical prognostic scores for BM patients including the graded prognostic assessment (GPA) and the GPA for gastrointestinal tumours (GI-GPA) were calculated based on clinical characteristics as previously published. Results: 215 (male: 125/215 (58.1%); female 90/215 (41.9%)) patients with CRC BM were available for this study. The following established clinical prognostic factors showed a significant association with median overall survival (OS) times from BM diagnosis: number of brain metastases (n = 1: 6 months; n = 2-3: 4 months; n > 3: 3 months; p = 0.001), age at BM diagnosis ( < 65 years: 6 months; > 65 years: 4 months; p = 0.047), extracranial disease (present: 4 months; absent: 8 months; p = 0.002) and Karfnofsky performance score (KPS < 70%: 3 months; KPS > 70%: 5 months; p = 0.002), graded prognostic assessment (GPA) class (class I: 15 months; class II: 13 months; class III: 4 months; class IV: 4 months) and the gastro-intestinal disease-specific GI-GPA (class I: 11 months; class II: 6 months; class III: 6 months; class IV: 3 months; p < 0.001). In addition, the location of the primary tumour in the left colon (n = 176 (81.9%); 5 months) was associated with significantly longer median overall survival times from diagnosis of BM than primary tumour location in the right colon (n = 39 (18.1%); 3 months; p = 0.010). Primary tumor sidedness (HR 0.577; 95% CI 0.397-0.841; p = 0.004) remained a strong prognostic factor at multivariate analysis independently of GI-GPA (HR 0.718; 95% CI 0.612-0.842). Conclusions: Primary tumor sidedness is an independent prognostic factor in patients with CRC BM and should be included in disease-specific prognostic scores. </jats:p> |
| doi_str_mv | 10.1200/jco.2017.35.15_suppl.3562 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNy4zNS4xNV9zdXBwbC4zNTYy |
| imprint | American Society of Clinical Oncology (ASCO), 2017 |
| imprint_str_mv | American Society of Clinical Oncology (ASCO), 2017 |
| institution | DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229 |
| issn | 1527-7755, 0732-183X |
| issn_str_mv | 1527-7755, 0732-183X |
| language | English |
| last_indexed | 2024-03-01T11:53:32.444Z |
| match_str | berghoff2017primarytumorsidednessassociateswithprognosisofpatientswithbrainmetastasesofcolorectalcancer |
| mega_collection | American Society of Clinical Oncology (ASCO) (CrossRef) |
| physical | 3562-3562 |
| publishDate | 2017 |
| publishDateSort | 2017 |
| publisher | American Society of Clinical Oncology (ASCO) |
| record_format | ai |
| recordtype | ai |
| series | Journal of Clinical Oncology |
| source_id | 49 |
| spelling | Berghoff, Anna Sophie Ferreira, Pedro Plazer, Hanna Widhalm, Georg Birner, Peter Bartsch, Rupert Prager, Gerald W. Zielinski, Christoph Preusser, Matthias 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2017.35.15_suppl.3562 <jats:p> 3562 </jats:p><jats:p> Background: Brian metastases (BM) are a rare but devastating complication of colorectal cancer. We aimed to analyse prognostic factors in patients suffering from colorectal cancer (CRC) BM. Methods: Patients with histological proven CRC and BM were identified from the brain metastasis database of the Comprehensive Cancer Center Vienna. Clinical characteristics including established prognostic factors were retrieved by chart review. Established clinical prognostic scores for BM patients including the graded prognostic assessment (GPA) and the GPA for gastrointestinal tumours (GI-GPA) were calculated based on clinical characteristics as previously published. Results: 215 (male: 125/215 (58.1%); female 90/215 (41.9%)) patients with CRC BM were available for this study. The following established clinical prognostic factors showed a significant association with median overall survival (OS) times from BM diagnosis: number of brain metastases (n = 1: 6 months; n = 2-3: 4 months; n > 3: 3 months; p = 0.001), age at BM diagnosis ( < 65 years: 6 months; > 65 years: 4 months; p = 0.047), extracranial disease (present: 4 months; absent: 8 months; p = 0.002) and Karfnofsky performance score (KPS < 70%: 3 months; KPS > 70%: 5 months; p = 0.002), graded prognostic assessment (GPA) class (class I: 15 months; class II: 13 months; class III: 4 months; class IV: 4 months) and the gastro-intestinal disease-specific GI-GPA (class I: 11 months; class II: 6 months; class III: 6 months; class IV: 3 months; p < 0.001). In addition, the location of the primary tumour in the left colon (n = 176 (81.9%); 5 months) was associated with significantly longer median overall survival times from diagnosis of BM than primary tumour location in the right colon (n = 39 (18.1%); 3 months; p = 0.010). Primary tumor sidedness (HR 0.577; 95% CI 0.397-0.841; p = 0.004) remained a strong prognostic factor at multivariate analysis independently of GI-GPA (HR 0.718; 95% CI 0.612-0.842). Conclusions: Primary tumor sidedness is an independent prognostic factor in patients with CRC BM and should be included in disease-specific prognostic scores. </jats:p> Primary tumor sidedness associates with prognosis of patients with brain metastases of colorectal cancer. Journal of Clinical Oncology |
| spellingShingle | Berghoff, Anna Sophie, Ferreira, Pedro, Plazer, Hanna, Widhalm, Georg, Birner, Peter, Bartsch, Rupert, Prager, Gerald W., Zielinski, Christoph, Preusser, Matthias, Journal of Clinical Oncology, Primary tumor sidedness associates with prognosis of patients with brain metastases of colorectal cancer., Cancer Research, Oncology |
| title | Primary tumor sidedness associates with prognosis of patients with brain metastases of colorectal cancer. |
| title_full | Primary tumor sidedness associates with prognosis of patients with brain metastases of colorectal cancer. |
| title_fullStr | Primary tumor sidedness associates with prognosis of patients with brain metastases of colorectal cancer. |
| title_full_unstemmed | Primary tumor sidedness associates with prognosis of patients with brain metastases of colorectal cancer. |
| title_short | Primary tumor sidedness associates with prognosis of patients with brain metastases of colorectal cancer. |
| title_sort | primary tumor sidedness associates with prognosis of patients with brain metastases of colorectal cancer. |
| title_unstemmed | Primary tumor sidedness associates with prognosis of patients with brain metastases of colorectal cancer. |
| topic | Cancer Research, Oncology |
| url | http://dx.doi.org/10.1200/jco.2017.35.15_suppl.3562 |